Sean Williamson

✨Educational opportunity in uropathology:
The 1st Luso-Brazilian Course in Uropathology is open for registration!

🔗 Register here: zoom.us/webinar/regi...

#GUpath #MedicalEducation

10.02.2026 17:50 — 👍 3    🔁 3    💬 2    📌 0

Can we consider Gleason 3+3 (Grade Group 1) to be like endometrial complex atypical hyperplasia? Once there is a certain amount of confluence it becomes cancer?

31.01.2025 18:12 — 👍 0    🔁 0    💬 0    📌 0

Is Gleason 6 really cancer? The recently published Viewpoint of the National Cancer Institute working group on "Overdiagnosis and Overtreatment in Cancer" by Esserman and colleagues [1] raises continued discussion as to whether ...

Here are my thoughts from several years ago, but I think still hold mostly true!

www.bjuinternational.com/bjui-blog/is...

31.01.2025 18:12 — 👍 1    🔁 0    💬 1    📌 0

Should grade group 1 prostate cancer be renamed? Experts debate the pros and cons of a ‘noncancer’ nomenclature change January 2025—Whether grade gr...

A nice article from CAP Today - should low-grade prostate cancer be renamed?

www.captodayonline.com/should-grade...

31.01.2025 18:12 — 👍 1    🔁 0    💬 1    📌 0

Gender Gender offers an added layer of specificity when interpreting patterns or phenomena of human behavior. Authors are strongly encouraged to explicitly designate information about the gender identities of the participants making up their samples rather than assuming cisgender identities.

It always bothers me when authors refer to patients as males/females (as nouns) in scientific papers. We ask authors to change it for IJSP

Here is a great explanation! bit.ly/42bBWkH

28.12.2024 14:26 — 👍 1    🔁 1    💬 0    📌 0

Just learned about bluesky! For a first post, here is an image of ductal type prostate cancer. Diagnostic criteria can be controversial but common features are columnar cells and papillary structures. Typically considered grade 4. #GUpath

12.12.2024 16:24 — 👍 11    🔁 5    💬 2    📌 0